Pune, India -- (SBWIRE) -- 03/26/2018 -- Lancets are one of the widely used alternative devices to obtain blood samples. Lancets are receiving global recognition and acceptance due to its several convenient characteristics which gives them an edge over the traditional methods for vein puncture. Some of the important features of the safety lancets are painless vein puncture, easy handling, and safety while using. The major applications of the safety lancets are capillary blood micro sampling, cholesterol test, hemoglobin (HBO) and HIV screening test, blood group test, coagulation tests, allergy tests, and many other blood-based tests.

The Global Lancet and Pen Needles Market is expected to grow at a CAGR of 10.30% during the forecast period, 2017-2027.

Major Players in the lancet and pen needles Market:

Some of the key players in this market are B. Braun Melsungen AG, Terumo Corporation, Becton Dickinson, Sanofi, F. Hoffmann-La Roche AG, Bayer AG, Novo Nordisk A S, Eli Lilly and Company, Owen Mumford Ltd, Medtronic, Ypsomed Holding AG, Sarstedt AG & Co, Greiner Bio One, Abbott Laboratories, HTL-STREFA S.A, Improve Medical, UltiMed, Inc., Allison Medical, Inc., Artsana S.p.a., VOGT MEDICAL, Perrigo Diabetes Care, MedExel Co., Ltd, ARKRAY Inc., Simple Diagnostics, Stat Medical, Terumo, Trividia Health, and others.

The global lancet and pen needles market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

Get Sample copy of Lancet and Pen Needles Market Report@ https://www.marketresearchfuture.com/sample_request/555 .

Market Highlights:

Rising cases of blood infections coupled with increasing focus on the development of drug delivery methods are the major factor affirming positive growth of this market.

Incidence of contagious diseases is increasing rapidly on a global level, some of these diseases include Hantavirus pulmonary syndrome, HIV/AIDS, Lyme disease, hemolytic uremic syndrome, and others. The need to monitor these diseases along with the requirement of advanced techniques for drug delivery methods associated with the non-contagious diseases such as diabetes mellitus, chronic kidney diseases, lung disease, and some heart diseases are expected to impact the growth of global lancets and pen needle market. There are over 35 million healthcare workers globally. These workers face an increased risk of infection from blood-borne pathogens simply because of their exposure to blood and other bodily fluids (World Health Organization (WHO)). Infectious disease such as plaque (Black Death) reported an estimated 50 million deaths in the 14th century (WHO).

Europe dominates the global lancet & pen needles market owing to the increasing prevalence of patients suffering with diabetes. The Europe lancet & pen needles market comprises of Eastern Europe and Western Europe. Western Europe comprises of countries such as Germany, the U.K, France, Italy, and Spain. Moreover, increasing support from the government, presence of huge geriatric population, and high healthcare spending will boost the market growth over the forecast period.

The Americas hold the second largest market share in the global lancet and pen needles market owing to the increasing prevalence of patients suffering with contagious and non-contagious diseases.

Asia Pacific is the fastest growing market for the global lancet and pen needles. Presence of huge patient population, rapid development in technology, and presence of a huge opportunity for the development of the market drives the growth of Asia Pacific lancet and pen needles market.

List of Tables:

TABLE 1 GLOBAL LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION) 39
TABLE 2 GLOBAL LANCET AND PEN NEEDLES MARKET, BY LANCET, 2014-2027 (USD MILLION) 40
TABLE 3 GLOBAL LANCET AND PEN NEEDLES MARKET, BY PEN NEEDLES, 2014-2027 (USD MILLION) 42
TABLE 4 GLOBAL LANCET AND PEN NEEDLES MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 44
TABLE 5 GLOBAL LANCET AND PEN NEEDLES MARKET, BY INSULIN, 2014-2027 (USD MILLION) 46
TABLE 6 GLOBAL LANCET AND PEN NEEDLES MARKET, BY CAPILLARY BLOOD SAMPLING, 2014-2027 (USD MILLION) 46
TABLE 7 GLOBAL LANCET AND PEN NEEDLES MARKET, BY HORMONES, 2014-2027 (USD MILLION) 47
TABLE 8 GLOBAL LANCET AND PEN NEEDLES MARKET, BY GLUCOSE LIKE PEPTIDE (GLP), 2014-2027 (USD MILLION) 47
TABLE 9 GLOBAL LANCET AND PEN NEEDLES MARKET, BY SKIN TESTING, 2014-2027 (USD MILLION) 48
TABLE 10 GLOBAL LANCET AND PEN NEEDLES MARKET, BY END USER, 2014-2027 (USD MILLION) 49
TABLE 11 GLOBAL LANCET AND PEN NEEDLES MARKET BY HOSPITALS & CLINICS, 2014-2027 (USD MILLION) 51
TABLE 12 GLOBAL LANCET AND PEN NEEDLES MARKET BY DIAGNOSTIC CENTERS & MEDICAL INSTITUTIONS,
2014-2027 (USD MILLION) 51
TABLE 13 GLOBAL LANCET AND PEN NEEDLES MARKET BY HOME CARE & HOME DIAGNOSTICS, 2014-2027
(USD MILLION) 52
TABLE 14 GLOBAL LANCET AND PEN NEEDLES MARKET BY RESEARCH & ACADEMIC LABORATORIES,
2014-2027 (USD MILLION) 53
TABLE 15 EUROPE LANCET AND PEN NEEDLES MARKET, BY COUNTRY, 2014- 2027 (USD MILLION) 56

And more…

Get Discount on Lancet and Pen Needles Market Report @ https://www.marketresearchfuture.com/check-discount/555 .

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com